esophageal cancer
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients who have primary esophageal cancer which is histologically confirmed -Performance status is 0-2 -No serious abnormality in heart, lung, bone marrow, liver, and renal functions -obtain informed consent
Exclusion criteria
Exclusion criteria: Patients who have: -narrowing of esophago-intestinal lumen -Serious milk allergy -Serious abnormality in liver and renal
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| frequency of chemotherapy-related adverse effects, especially hematotoxicity | — |
Secondary
| Measure | Time frame |
|---|---|
| frequency of other chemotherapy-related adverse effects nutrition status feasibility of agjuvant chemotherapy | — |
Countries
Japan
Contacts
Graduate School of Medicine, Osaka University Department of Gastroenterological Surgery